🔴 Corcept Therapeutics is trading 10.9% down today with no new company-specific catalyst identified

Corcept Therapeutics is trading at $95.74, with a -10.94% change; no new catalyst was identified for October 23.

• Available coverage reports no new macro, sector or company-specific catalysts for the company today.
• Biotech stocks are weaker, with XBI down 2.08% in the regular session, offering sector context.
• The prior session’s steep drop and broader risk-off backdrop may be adding pressure, but available evidence does not establish a direct cause for today’s move.